Monitoring Specific T-Cell Responses to Melanoma Vaccines: ELISPOT, Tetramers, and Beyond

Por Gajewski, Thomas F.
Publicado em 2000

Molecular profiling of melanoma and the evolution of patient-specific therapy

Por Gajewski, Thomas F.
Publicado em 2011

Cancer immunotherapy

Por Gajewski, Thomas F.
Publicado em 2012

The next hurdle in cancer immunotherapy: Overcoming the non-T cell-inflamed tumor microenvironment

Por Gajewski, Thomas F.
Publicado no Semin Oncol (2015)

An adenoviral vector encoding dominant negative Cbl lowers the threshold for T cell activation in post-thymic T cells

Por Zha, Yuanyuan, Gajewski, Thomas F.
Publicado em 2007

New perspectives on type I IFNs in cancer

Por Gajewski, Thomas F., Corrales, Leticia
Publicado no Cytokine Growth Factor Rev (2015)

A new paradigm for tumor immune escape: β-catenin-driven immune exclusion

Por Spranger, Stefani, Gajewski, Thomas F.
Publicado no J Immunother Cancer (2015)

Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy

Por Corrales, Leticia, Gajewski, Thomas F.
Publicado no Cytokine (2015)

Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer

Por Corrales, Leticia, Gajewski, Thomas F.
Publicado no Clin Cancer Res (2015)

Tumor-intrinsic oncogene pathways mediating immune avoidance

Por Spranger, Stefani, Gajewski, Thomas F.
Publicado no Oncoimmunology (2015)

Targeted therapeutics in melanoma

Por Gajewski, Thomas F., Hodi, F. Stephen.
Publicado em 2012

Molecular regulation of T-cell anergy

Por Zheng, Yan, Zha, Yuanyuan, Gajewski, Thomas F
Publicado em 2008

PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model

Por Zhang, Long, Gajewski, Thomas F., Kline, Justin
Publicado em 2009

Costimulatory and coinhibitory receptors in anti-tumor immunity

Por Driessens, Gregory, Kline, Justin, Gajewski, Thomas F.
Publicado em 2009

Immune surveillance is thwarted by tumor-cell intrinsic beta-catenin signaling

Por Spranger, Stefani, Horton, Brendan, Gajewski, Thomas F
Publicado no J Immunother Cancer (2015)

MYC — a thorn in the side of cancer immunity

Por Spranger, Stefani, Gajewski, Thomas F, Kline, Justin
Publicado no Cell Res (2016)

B7-1 Engagement of Cytotoxic T Lymphocyte Antigen 4 Inhibits T Cell Activation in the Absence of CD28

Por Fallarino, Francesca, Fields, Patrick E., Gajewski, Thomas F.
Publicado em 1998

Extremely potent immunotherapeutic activity of a STING agonist in the B16 melanoma model in vivo

Por Corrales, Leticia, Woo, Seng-Ryong, Gajewski, Thomas F
Publicado em 2013

Innate and adaptive immune cells in the tumor microenvironment

Por Gajewski, Thomas F, Schreiber, Hans, Fu, Yang-Xin
Publicado em 2013

Primary Murine CD4(+) T Cells Fail to Acquire the Ability to Produce Effector Cytokines When Active Ras Is Present during Th1/Th2 Differentiation

Por Janardhan, Sujit V., Marks, Reinhard, Gajewski, Thomas F.
Publicado no PLoS One (2014)